SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...

Small-group discussions designed to help elementary students engage in conversations that promote critical analytic thinking, ...

A novel once-daily oral PCSK9 inhibitor lowered LDL by up to 60% at 24 weeks in patients with heart disease or at high risk ...

Market noise is intensifying, showcasing why buying and holding stocks at all-time highs takes focus and conviction.

Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...

The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with ...

Advanced Micro Devices, Inc.'s Q3 earnings, AI GPU sales, and OpenAI partnership highlight future potential vs. current challenges. Click for this AMD update.

Last week, artificial intelligence (AI) music company Udio announced an out-of-court settlement with Universal Music Group ...

Multiple TNF inhibitors, as well as interleukin-17 blockers such as secukinumab (Cosentyx) and Janus kinase (JAK) inhibitors ...

UK businesses are preparing for what possibly could be a tighter financial climate as the government faces a large ...

For Medicaid care management, focusing on rising-risk patients is more effective than targeting high-cost claimants, whose spending tends to decrease over time due to regression to the mean.

Women with myasthenia gravis have higher rates of preterm birth and cesarean delivery, new findings show, underscoring the need for careful pregnancy management and monitoring.